The kick-off trilogue on the Critical Medicines Act (CMA) took place on Monday evening (2 February), with discussions described as constructive. Co-legislators reiterated both their readiness to move forward and the urgency of the file, given ongoing concerns around the EU’s security of medicine supply.
Earlier that afternoon, addressing the European Parliament’s Public Health Committee, Cypriot Health Minister Neophytos Charalambides said the CMA was a key priority of the Cypriot presidency. He expressed hope that a political agreement could be reached within the next six months.
“This is a top priority for us in the current geopolitical context, where the availability of medicines can be challenged. Strengthening our capacity to provide critical medicines is key. We must ensure that every citizen has reliable access to the medicines they need,” Charalambides said.
The trilogue comes as European Commission Vice President and Industry Commissioner Stéphane Séjourné called for the EU to adopt a “European preference”…
